Assurex Health, Inc.

Member Type: Diagnostic Companies

The company was founded in 2006 to license and commercialize pharmacogenetic technology from Cincinnati Children’s Hospital Medical Center and Mayo Clinic.  The technology utilized in the AssureRx non-invasive, pharmacogenetic test measures, analyzes and interprets the genes of patients with common neuro-psychiatric disorders to predict which drugs are best choices for each specific patient.  The test helps to take much of the guesswork out of prescribing medications.

Pharmacogenetics helps physicians determine how an individual patient will respond to an individual drug, and at what dose.  AssureRx analyzes not just one gene, but several genes to predict how patients will respond to medicines.  The patent-pending technology takes many genetic variables into consideration and translates the data into a report for doctors within 48 hours of receiving a sample from a patient.

Join Today

PMC members shape and advance the future of personalized medicine.
» Sign Up Today

Talk to Us

To learn more about PMC membership, contact PMC Director of Membership & Development Mary Bordoni.

Download a Member List